Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen

References

• Banker D. Preliminary observations on antibody patterns against certain viruses among inhabitants of Bombay city. Ind J Med Sci. 1952;6:733–746.
   Google Scholar
• Bondre VP, Jadi RS, Mishra AC, et al. West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol. 2007;88:875–884.
   PubMed Web of Science ®Google Scholar
• Lindsey NP, Lehman JA, Erin Staples J, et al. West Nile Virus and other Arboviral Diseases — United States, 2013 [Internet]. Centers for Disease Control and Prevention, Atlanta, Georgia, USA; 2014. [cited 2016 Jan 31]. Available from: http://www.cdc.gov/mmwr/pdf/wk/mm6324.pdf.
   Google Scholar
• Preliminary Maps & Data for 2015 | West Nile Virus | CDC [Internet]. 2016. [cited 2016 Jan 31] Available from: http://www.cdc.gov/westnile/statsmaps/preliminarymapsdata/index.html.
   Google Scholar
• Di Sabatino D, Bruno R, Sauro F, et al. Epidemiology of West Nile Disease in Europe and in the Mediterranean Basin from 2009 to 2013. BioMed Res Int 2014;2014:1–10.
   Web of Science ®Google Scholar
• Petersen LR, Brault AC, Nasci RS. West Nile Virus: review of the literature. JAMA. 2013;310:308.
   PubMed Web of Science ®Google Scholar
• Baqar S, Hayes CG, Murphy JR, et al. Vertical transmission of West Nile virus by Culex and Aedes species mosquitoes. Am J Trop Med Hyg. 1993;48:757–762.
   PubMed Web of Science ®Google Scholar
• Hubálek Z, Halouzka J. West Nile fever–a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis. 1999;5:643–650.
   PubMed Web of Science ®Google Scholar
• Dandawate CN, Rajagopalan PK, Pavri KM, et al. Virus isolations from mosquitoes collected in North Arcot district, Madras state, and Chittoor district, Andhra Pradesh between November 1955 and October 1957. Indian J Med Res. 1969;57:1420–1426.
   PubMed Web of Science ®Google Scholar
• Umrigar MD, Pavri KM. Comparative biological studies on Indian strains of West Nile virus isolated from different sources. Indian J Med Res. 1977;65:596–602.
   PubMed Web of Science ®Google Scholar
• Andreadis TG, Anderson JF, Vossbrinck CR. Mosquito surveillance for West Nile virus in Connecticut, 2000: isolation from Culex pipiens, Cx. restuans, Cx. salinarius, and Culiseta melanura. Emerg Infect Dis. 2001;7:670–674.
   PubMed Web of Science ®Google Scholar
• Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45:1039–1046.
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Uzcátegui NY, Gould EA, et al. Ixodid and argasid tick species and West Nile virus. Emerg Infect Dis. 2004;10:653–657.
   PubMed Web of Science ®Google Scholar
• Nelms BM, Fechter-Leggett E, Carroll BD, et al. Experimental and natural vertical transmission of West Nile virus by California Culex (Diptera: Culicidae) mosquitoes. J Med Entomol. 2013;50:371–378.
   PubMed Web of Science ®Google Scholar
• Gubler J Dane. The continuing spread of West Nile virus in Western Hemisphere. Clin Infect Dis. 2007;45:1030–1045.
   PubMed Web of Science ®Google Scholar
• Higgs S, Schneider BS, Vanlandingham DL, et al. Nonviremic transmission of West Nile virus. Proc Natl Acad Sci USA. 2005;102:8871–8874.
   PubMed Web of Science ®Google Scholar
• Komar N, Langevin S, Hinten S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis. 2003;9:311–322.
   PubMed Web of Science ®Google Scholar
• Pérez-Ramírez E, Llorente F, Jiménez-Clavero MÁ. Experimental infections of wild birds with West Nile virus. Viruses. 2014;6:752–781.
   PubMed Web of Science ®Google Scholar
• Rappole JH, Derrickson SR, Hubálek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis. 2000;6:319–328.
   PubMed Web of Science ®Google Scholar
• Calistri P, Giovannini A, Hubalek Z, et al. Epidemiology of west nile in europe and in the mediterranean basin. Open Virol J. 2010;4:29–37.
   PubMedGoogle Scholar
• George S, Gourie-Devi M, Rao JA, et al. Isolation of West Nile virus from the brains of children who had died of encephalitis. Bull World Health Organ. 1984;62:879–882.
   PubMed Web of Science ®Google Scholar
• Paul SD, Murthy DP, Das M. Isolation of West Nile virus from a human case of febrile illness. Indian J Med Res. 1970;58:1177–1179.
   PubMed Web of Science ®Google Scholar
• Kedarnath N, Prasad SR, Dandawate CN, et al. Isolation of Japanese encephalitis & West Nile viruses from peripheral blood of encephalitis patients. Indian J Med Res. 1984;79:1–7.
   PubMed Web of Science ®Google Scholar
• Paul SD, Rajagopalan PK, Sreenivasan MA. Isolation of the West Nile virus from the frugivorous bat, Rousettus leschenaulti. Indian J Med Res. 1970;58:1169–1171.
   PubMed Web of Science ®Google Scholar
• Pavri KM, Singh KRP. Isolation of West Nile virus from Culex Fatigans Mosquitoes from Western India. Ind J Med Res. 1965;53:501–555.
   PubMed Web of Science ®Google Scholar
• Mishra N, Kalaiyarasu S, Nagarajan S, et al. Serological evidence of West Nile virus infection in wild migratory and resident water birds in Eastern and Northern India. Comp Immunol Microbiol Infect Dis. 2012;35:591–598.
   PubMed Web of Science ®Google Scholar
• Rodrigues FM, Guttikar SN, Pinto BD. Prevalence of antibodies to Japanese encephalitis and West Nile viruses among wild birds in the Krishna-Godavari Delta, Andhra Pradesh, India. Trans R Soc Trop Med Hyg. 1981;75:258–262.
   PubMed Web of Science ®Google Scholar
• Chancey C, Grinev A, Volkova E, et al. The Global Ecology and Epidemiology of West Nile Virus. Bio Med Res Int. 2015;2015:1–20.
   Web of Science ®Google Scholar
• Ratho RK, Sethi S, Prasad SR. Prevalence of Japanese encephalitis and West Nile viral infections in pig population in and around Chandigarh. J Commun Dis. 1999;31:113–116.
   PubMedGoogle Scholar
• Stramer SL, Fang CT, Foster GA, et al. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med. 2005;353:451–459.
   PubMed Web of Science ®Google Scholar
• Winston DJ, Vikram HR, Rabe IB, et al. Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features. Transplantation. 2014;97:881–889.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Possible West Nile virus transmission to an infant through breast-feeding–Michigan, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:877–878.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Intrauterine West Nile virus infection–New York, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1135–1136.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Laboratory-acquired West Nile virus infections–United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:1133–1135.
   PubMedGoogle Scholar
• Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003;349:1236–1245.
   PubMed Web of Science ®Google Scholar
• Meny GM, Santos-Zabala L, Szallasi A, et al. West Nile virus infection transmitted by granulocyte transfusion. Blood. 2011;117:5778–5779.
   PubMed Web of Science ®Google Scholar
• May FJ, Davis CT, Tesh RB, et al. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol. 2011;85:2964–2974.
   PubMed Web of Science ®Google Scholar
• Gray TJ, Webb CE. A review of the epidemiological and clinical aspects of West Nile virus. Int J Gen Med. 2014;7:193–203.
   PubMedGoogle Scholar
• Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science. 1999;286:2333–2337.
   PubMed Web of Science ®Google Scholar
• Balakrishnan A, Butte DK, Jadhav SM. Complete genome sequence of West Nile virus isolated from alappuzha district, Kerala, India. Genome Announc. 2013;1:e00230–13.
   Google Scholar
• Gray TJ, Burrow JN, Markey PG, et al. West Nile virus (Kunjin subtype) disease in the northern territory of Australia–a case of encephalitis and review of all reported cases. Am J Trop Med Hyg. 2011;85:952–956.
   PubMed Web of Science ®Google Scholar
• Hall RA, Scherret JH, Mackenzie JS. Kunjin virus: an Australian variant of West Nile? Ann N Y Acad Sci. 2001;951:153–160.
   PubMed Web of Science ®Google Scholar
• Barzon L, Papa A, Pacenti M, et al. Genome sequencing of West Nile Virus from human cases in Greece, 2012. Viruses. 2013;5:2311–2319.
   PubMed Web of Science ®Google Scholar
• Magurano F, Remoli ME, Baggieri M, et al. Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18:E545–E547.
   Google Scholar
• Aliota MT, Jones SA, Dupuis AP, et al. Characterization of Rabensburg virus, a flavivirus closely related to West Nile virus of the Japanese encephalitis antigenic group. PLoS One. 2012;7:e39387.
   Google Scholar
• Papa A, Bakonyi T, Xanthopoulou K, et al. Genetic characterization of West Nile virus lineage 2, Greece, 2010. Emerg Infect Dis. 2011;17:920–922.
   PubMed Web of Science ®Google Scholar
• Lvov DK, Butenko AM, Gromashevsky VL, et al. West Nile virus and other zoonotic viruses in Russia: examples of emerging-reemerging situations. Arch Virol Suppl. 2004;18:85–96.
   PubMedGoogle Scholar
• Vazquez A, Sanchez-Seco MP, Ruiz S, et al. Putative new lineage of West Nile virus, Spain. Emerg Infect Dis. 2010;16:549–552.
   PubMed Web of Science ®Google Scholar
• Pesko KN, Ebel GD. West Nile virus population genetics and evolution. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2012;12:181–190.
   PubMed Web of Science ®Google Scholar
• Grinev A, Daniel S, Stramer S, et al. Genetic variability of West Nile virus in US blood donors, 2002-2005. Emerg Infect Dis. 2008;14:436–444.
   PubMed Web of Science ®Google Scholar
• Smithburn KC, Jacobs HR. Neutralization-tests. Neurotrop Viruses Sera Collect Cent Afr. 1942;44:9–23.
   Google Scholar
• Cabre O, Grandadam M, Marié J-L, et al. West Nile Virus in horses, sub-Saharan Africa. Emerg Infect Dis. 2006;12:1958–1960.
   PubMed Web of Science ®Google Scholar
• Kading RC, Borland EM, Cranfield M, et al. Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin. J Wildl Dis. 2013;49:587–599.
   PubMed Web of Science ®Google Scholar
• Sghaier W, Bahri O, Kedous E, et al. [Retrospective study of viral causes of central nervous system infections in Tunisia (2003-2009)]. Médecine Santé Trop. 2012;22:373–378.
   Google Scholar
• Morrill JC, Johnson BK, Hyams C, et al. Serological evidence of arboviral infections among humans of coastal Kenya. J Trop Med Hyg. 1991;94:166–168.
   PubMedGoogle Scholar
• Burt FJ, Grobbelaar AA, Leman PA, et al. Phylogenetic relationships of southern African West Nile virus isolates. Emerg Infect Dis. 2002;8:820–826.
   PubMed Web of Science ®Google Scholar
• Zaayman D, Venter M. West Nile virus neurologic disease in humans, South Africa, September 2008-May 2009. Emerg Infect Dis. 2012;18:2051–2054.
   PubMed Web of Science ®Google Scholar
• Jentes ES, Robinson J, Johnson BW, et al. Acute arboviral infections in Guinea, West Africa, 2006. Am J Trop Med Hyg. 2010;83:388–394.
   PubMed Web of Science ®Google Scholar
• Wang W, Sarkodie F, Danso K, et al. Seroprevalence of West Nile virus in Ghana. Viral Immunol. 2009;22:17–22.
   PubMed Web of Science ®Google Scholar
• Mandji Lawson JM, Mounguengui D, Ondounda M, et al. [A case of meningo-encephalitis due to West Nile virus in Libreville, Gabon]. Médecine Trop Rev Corps Santé Colon. 2009;69:501–502.
   Google Scholar
• Baba M, Logue CH, Oderinde B, et al. Evidence of arbovirus co-infection in suspected febrile malaria and typhoid patients in Nigeria. J Infect Dev Ctries. 2013;7:51–59.
   PubMed Web of Science ®Google Scholar
• Melnick JL, Paul JR, Riordan JT, et al. Isolation from human sera in Egypt of a virus apparently identical to West Nile virus. Proc Soc Exp Biol Med Soc Exp Biol Med N Y N. 1951;77:661–665.
   PubMed Web of Science ®Google Scholar
• Bernkopf H, Levine S, Nerson R. Isolation of West Nile virus in Israel. J Infect Dis. 1953;93:207–218.
   PubMed Web of Science ®Google Scholar
• Goldblum N, Sterk VV, Paderski B. West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases. Am J Hyg. 1954;59:89–103.
   PubMed Web of Science ®Google Scholar
• Goldblum N, Jasinska-Klingberg W, Klingberg MA, et al. The natural history of West Nile Fever. I. Clinical observations during an epidemic in Israel. Am J Hyg. 1956;64:259–269.
   PubMedGoogle Scholar
• Monath TP. Flavivruses. Fields virology. New York: Raven Pres; 1985. p. 955–1004.
   Google Scholar
• Weinberger M, Pitlik SD, Gandacu D, et al. West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis. 2001;7:686–691.
   PubMed Web of Science ®Google Scholar
• Meço O. [West Nile arbovirus antibodies with hemagglutination inhibition (HI) in residents of Southeast Anatolia]. Mikrobiyoloji Bül. 1977;11:3–17.
   PubMedGoogle Scholar
• Naficy K, Saidi S. Serological survey on viral antibodies in Iran. Trop Geogr Med. 1970;22:183–188.
   PubMedGoogle Scholar
• Kalaycioglu H, Korukluoglu G, Ozkul A, et al. Emergence of West Nile virus infections in humans in Turkey, 2010 to 2011. Euro Surveill. 2012;17:20182.
   PubMedGoogle Scholar
• Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet Lond Engl. 2001;358:261–264.
   PubMed Web of Science ®Google Scholar
• Jia XY, Briese T, Jordan I, et al. Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet Lond Engl. 1999;354:1971–1972.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Human West Nile virus surveillance–Connecticut, New Jersey, and New York, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:265–268.
   PubMedGoogle Scholar
• Moudy RM, Meola MA, Morin L-LL, et al. A newly emergent genotype of West Nile virus is transmitted earlier and more efficiently by Culex mosquitoes. Am J Trop Med Hyg. 2007;77:365–370.
   PubMed Web of Science ®Google Scholar
• Government of Canada: surveillance of West Nile virus [Internet]. Updated: 05 January 2016 [cited 2016 Jan 24]. Available from: http://healthycanadians.gc.ca/diseases-conditions-maladiesaffections/disease-maladie/west-nile-nil-occidental/surveillance-eng.php. Accessed 24 January 2016.
   Google Scholar
• Komar N, Clark GG. West Nile virus activity in Latin America and the Caribbean. Rev Panam Salud Pública Pan Am J Public Health. 2006;19:112–117.
   PubMed Web of Science ®Google Scholar
• Hunsperger EA, McElroy KL, Bessoff K, et al. West Nile virus from blood donors, vertebrates, and mosquitoes, Puerto Rico, 2007. Emerg Infect Dis. 2009;15:1298–300.
   PubMed Web of Science ®Google Scholar
• Barrera R, Hunsperger E, Muñoz-Jordán JL, et al. First isolation of West Nile virus in the Caribbean. Am J Trop Med Hyg. 2008;78:666–668.
   PubMed Web of Science ®Google Scholar
• Elizondo-Quiroga D, Davis CT, Fernandez-Salas I, et al. West Nile Virus isolation in human and mosquitoes, Mexico. Emerg Infect Dis. 2005;11:1449–1452.
   PubMed Web of Science ®Google Scholar
• Rios-Ibarra C, Blitvich BJ, Farfan-Ale J, et al. Fatal human case of West Nile disease, Mexico, 2009. Emerg Infect Dis. 2010;16:741–743.
   PubMed Web of Science ®Google Scholar
• Cruz L, Cardenas VM, Abarca M, et al. Short report: serological evidence of West Nile virus activity in El Salvador. Am J Trop Med Hyg. 2005;72:612–615.
   PubMed Web of Science ®Google Scholar
• Morales-Betoulle ME, Komar N, Panella NA, et al. West Nile virus ecology in a tropical ecosystem in Guatemala. Am J Trop Med Hyg. 2013;88:116–126.
   PubMed Web of Science ®Google Scholar
• Hobson-Peters J, Arévalo C, Cheah WY, et al. Detection of antibodies to West Nile virus in horses, Costa Rica, 2004. Vector Borne Zoonotic Dis Larchmt N. 2011;11:1081–1084.
   PubMed Web of Science ®Google Scholar
• Monge Maillo B, López-Vélez R, Norman F, et al. Importation of West Nile virus infection from Nicaragua to Spain. Emerg Infect Dis. 2008;14:1171–1173.
   PubMed Web of Science ®Google Scholar
• Barzon L, Pacenti M, Franchin E, et al. Large human outbreak of West Nile virus infection in north-eastern Italy in 2012. Viruses. 2013;5:2825–2839.
   PubMed Web of Science ®Google Scholar
• Adrián Diaz L, Komar N, Visintin A, et al. West Nile virus in birds, Argentina. Emerg Infect Dis. 2008;14:689–691.
   PubMed Web of Science ®Google Scholar
• ProMED-mail [Internet]. 2016. [cited 2016 Jan 24] Available from: http://promedmail.org/
   Google Scholar
• Bosch I, Herrera F, Navarro J-C, et al. West Nile virus, Venezuela. Emerg Infect Dis. 2007;13:651–653.
   PubMed Web of Science ®Google Scholar
• Pauvolid-Corrêa A, Morales MA, Levis S, et al. Neutralising antibodies for West Nile virus in horses from Brazilian Pantanal. Mem Inst Oswaldo Cruz. 2011;106:467–474.
   PubMed Web of Science ®Google Scholar
• Platonov AE, Shipulin GA, Shipulina OY, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis. 2001;7:128–132.
   PubMed Web of Science ®Google Scholar
• Tsai TF, Popovici F, Cernescu C, et al. West Nile encephalitis epidemic in southeastern Romania. Lancet Lond Engl. 1998;352:767–771.
   PubMed Web of Science ®Google Scholar
• Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2004;23:147–156.
   PubMed Web of Science ®Google Scholar
• Bakonyi T, Ferenczi E, Erdélyi K, et al. Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008/2009. Vet Microbiol. 2013;165:61–70.
   PubMed Web of Science ®Google Scholar
• Barzon L, Pacenti M, Franchin E, et al. The complex epidemiological scenario of West Nile virus in Italy. Int J Environ Res Public Health. 2013;10:4669–4689.
   PubMed Web of Science ®Google Scholar
• Barzon L, Pacenti M, Franchin E, et al. Whole genome sequencing and phylogenetic analysis of West Nile virus lineage 1 and lineage 2 from human cases of infection, Italy, August 2013. Euro Surveill. 2013;18:20591.
   PubMedGoogle Scholar
• Napoli C, Bella A, Declich S, et al. Integrated human surveillance systems of West Nile virus infections in Italy: the 2012 experience. Int J Environ Res Public Health. 2013;10:7180–7192.
   PubMed Web of Science ®Google Scholar
• Stiasny K, Aberle SW, Heinz FX. Retrospective identification of human cases of West Nile virus infection in Austria (2009 to 2010) by serological differentiation from Usutu and other flavivirus infections. Euro Surveill. 2013;18:20614.
   PubMedGoogle Scholar
• Merdić E, Perić L, Pandak N, et al. West Nile virus outbreak in humans in Croatia, 2012. Coll Antropol. 2013;37:943–947.
   PubMedGoogle Scholar
• Morgan D. Control of arbovirus infections by a coordinated response: West Nile Virus in England and Wales. FEMS Immunol Med Microbiol. 2006;48:305–312.
   PubMedGoogle Scholar
• Doherty RL, Carley JG, Mackerras MJ, et al. Studies of arthropod-borne virus infections in Queensland. III. Isolation and characterization of virus strains from wild-caught mosquitoes in North Queensland. Aust J Exp Biol Med Sci. 1963;41:17–39.
   PubMedGoogle Scholar
• Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect Inst Pasteur. 2000;2:1693–1704.
   PubMed Web of Science ®Google Scholar
• Frost MJ, Zhang J, Edmonds JH, et al. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg Infect Dis. 2012;18:792–800.
   PubMed Web of Science ®Google Scholar
• Li X-L, Fu S-H, Liu W-B, et al. West Nile virus infection in Xinjiang, China. Vector Borne Zoonotic Dis Larchmt N. 2013;13:131–133.
   PubMed Web of Science ®Google Scholar
• Lohitharajah J, Malavige GN, Chua AJS, et al. Emergence of human West Nile Virus infection in Sri Lanka. BMC Infect Dis. 2015;15:305.
   PubMed Web of Science ®Google Scholar
• Hayes CG, Baqar S, Ahmed T, et al. West Nile virus in Pakistan. 1. Sero-epidemiological studies in Punjab Province. Trans R Soc Trop Med Hyg. 1982;76:431–436.
   PubMed Web of Science ®Google Scholar
• Pavri KM, Singh KR. Isolation of West Nile virus from Culex fatigans mosquitoes from western India. Indian J Med Res. 1965;53:501–505.
   PubMed Web of Science ®Google Scholar
• Smithburn KC, Kerr JA, Gatne PB. Neutralizing antibodies against certain viruses in the sera of residents of India. J Immunol Baltim Md 1950. 1954;72:248–257.
   Google Scholar
• Thakare JP, Rao TLG, Padbidri VS. Prevalence of West Nile virus infection in India. Southeast Asian J Trop Med Public Health. 2002;33:801–805.
   PubMedGoogle Scholar
• Risbud AR, Sharma V, Rao CV, et al. Post-epidemic serological survey for JE virus antibodies in south Arcot district (Tamil Nadu). Indian J Med Res. 1991;93:1–5.
   PubMed Web of Science ®Google Scholar
• Gajanana A, Thenmozhi V, Samuel PP, et al. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic. Bull World Health Organ. 1995;73:237–244.
   PubMed Web of Science ®Google Scholar
• Katyal R, Bhardwaj M, Harit AK, et al. Dengue, Japanese encephalitis, and West Nile Flaviviral infections detected during a Dengue Outbreak in Sonepat District, Haryana State, India. Dengue Bulletin 2004;28:24–28.
   Google Scholar
• Khan SA, Dutta P, Khan AM, et al. West Nile virus infection, Assam, India. Emerg Infect Dis. 2011;17:947–948.
   PubMed Web of Science ®Google Scholar
• Anukumar B, Sapkal GN, Tandale BV, et al. West Nile encephalitis outbreak in Kerala, India, 2011. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2014;61:152–155.
   Web of Science ®Google Scholar
• Shukla J, Saxena D, Rathinam S, et al. Molecular detection and characterization of West Nile virus associated with multifocal retinitis in patients from southern India. Int J Infect Dis. 2012;16:e53–e59.
   Google Scholar
• Maramattom BV, Philips G, Sudheesh N, et al. Acute flaccid paralysis due to West nile virus infection in adults: a paradigm shift entity. Ann Indian Acad Neurol. 2014;17:85–88.
   PubMed Web of Science ®Google Scholar
• Chambers TJ, Hahn CS, Galler R, et al. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649–688.
   PubMed Web of Science ®Google Scholar
• Macdonald J, Tonry J, Hall RA, et al. NS1 protein secretion during the acute phase of West Nile virus infection. J Virol. 2005;79:13924–13933.
   PubMed Web of Science ®Google Scholar
• Mackenzie JM, Khromykh AA, Jones MK, et al. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology. 1998;245:203–215.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Chen HB, Khromykh AA. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. J Virol. 2003;77:7804–813.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Wang XJ, Clark DC, et al. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol. 2006;80:2396–2404.
   PubMed Web of Science ®Google Scholar
• Chappell KJ, Stoermer MJ, Fairlie DP, et al. Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity. J Gen Virol. 2008;89:1010–1014.
   PubMed Web of Science ®Google Scholar
• Valiakos G, Athanasiou LV, Touloudi A, Papatsiros V, et al. West Nile Virus: basic principles, replication mechanism, immune response and important genetic determinants of virulence. In: Rosas-Acosta G, editor. Viral Replication [Internet]. Intech; 2013. [cited 2016 Jan 24] Available from: http://www.intechopen.com/books/viral-replication/west-nile-virus-basic-principles-replication-mechanism-immune-response-and-important-genetic-determi.
   Google Scholar
• Brinton MA, Diamond MS. Molecular biology of West Nile virus. West Nile Encephalitis Virus Infection. Springer; 2009. pp 97–136.
   Google Scholar
• Zhang Y, Corver J, Chipman PR, et al. Structures of immature flavivirus particles. EMBO J. 2003;22:2604–2613.
   PubMed Web of Science ®Google Scholar
• Stadler K, Allison SL, Schalich J, et al. Proteolytic activation of tick-borne encephalitis virus by furin. J Virol. 1997;71:8475–8481.
   PubMed Web of Science ®Google Scholar
• Kuhn RJ, Zhang W, Rossmann MG, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002;108:717–725.
   PubMed Web of Science ®Google Scholar
• Nelson S, Jost CA, Xu Q, et al. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog. 2008;4:e1000060.
   PubMed Web of Science ®Google Scholar
• Nybakken GE, Nelson CA, Chen BR, et al. Crystal structure of the West Nile virus envelope glycoprotein. J Virol. 2006;80:11467–11474.
   PubMed Web of Science ®Google Scholar
• Smit JM, Moesker B, Rodenhuis-Zybert I, et al. Flavivirus cell entry and membrane fusion. Viruses. 2011;3:160–171.
   PubMed Web of Science ®Google Scholar
• Davis CW, Nguyen H-Y, Hanna SL, et al. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol. 2006;80:1290–1301.
   PubMed Web of Science ®Google Scholar
• Chu JJ-H, Ng M-L. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. J Biol Chem. 2004;279:54533–54541.
   PubMed Web of Science ®Google Scholar
• Krishnan MN, Sukumaran B, Pal U, et al. Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol. 2007;81:4881–4885.
   PubMed Web of Science ®Google Scholar
• Thepparit C, Smith DR. Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol. 2004;78:12647–12656.
   PubMed Web of Science ®Google Scholar
• Chen YC, Wang SY, King CC. Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol. 1999;73:2650–2657.
   PubMed Web of Science ®Google Scholar
• Jindadamrongwech S, Thepparit C, Smith DR. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch Virol. 2004;149:915–927.
   PubMed Web of Science ®Google Scholar
• Reyes-Del Valle J, Chávez-Salinas S, Medina F, et al. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol. 2005;79:4557–4567.
   PubMed Web of Science ®Google Scholar
• Bogachek MV, Protopopova EV, Loktev VB, et al. Immunochemical and single molecule force spectroscopy studies of specific interaction between the laminin binding protein and the West Nile virus surface glycoprotein E domain II. J Mol Recognit JMR. 2008;21:55–62.
   PubMed Web of Science ®Google Scholar
• Chu JJH, Ng ML. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol. 2004;78:10543–10555.
   PubMed Web of Science ®Google Scholar
• Liao M, Sánchez-San Martín C, Zheng A, et al. In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J Virol. 2010;84:5730–5740.
   PubMed Web of Science ®Google Scholar
• Konishi E, Mason PW. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol. 1993;67:1672–1675.
   PubMed Web of Science ®Google Scholar
• Wengler G, Wengler G. Cell-associated West Nile flavivirus is covered with E + pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol. 1989;63:2521–2526.
   PubMed Web of Science ®Google Scholar
• Byrne SN, Halliday GM, Johnston LJ, et al. Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol. 2001;117:702–709.
   PubMed Web of Science ®Google Scholar
• Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis. 2008;198:984–993.
   PubMed Web of Science ®Google Scholar
• Tonry JH, Brown CB, Cropp CB, et al. West Nile virus detection in urine. Emerg Infect Dis. 2005;11:1294–1296.
   PubMed Web of Science ®Google Scholar
• Samuel MA, Diamond MS. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol. 2005;79:13350–13361.
   PubMed Web of Science ®Google Scholar
• Rossi SL, Ross TM, Evans JD. West Nile virus. Clin Lab Med. 2010;30:47–65.
   PubMed Web of Science ®Google Scholar
• Arjona A, Foellmer HG, Town T, et al. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest. 2007;117:3059–3066.
   PubMed Web of Science ®Google Scholar
• Dai J, Wang P, Bai F, et al. Icam-1 participates in the entry of West Nile virus into the central nervous system. J Virol. 2008;82:4164–4168.
   PubMed Web of Science ®Google Scholar
• Wang P, Dai J, Bai F, et al. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol. 2008;82:8978–8985.
   PubMed Web of Science ®Google Scholar
• Wang S, Welte T, McGargill M, et al. Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J Immunol. 2008;181:2084–2091.
   PubMed Web of Science ®Google Scholar
• Wang T, Town T, Alexopoulou L, et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med. 2004;10:1366–1373.
   PubMed Web of Science ®Google Scholar
• Garcia-Tapia D, Hassett DE, Mitchell WJ, et al. West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection. J Neurovirol. 2007;13:130–138.
   PubMed Web of Science ®Google Scholar
• Verma S, Lo Y, Chapagain M, et al. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in vitro blood-brain barrier. Virology. 2009;385:425–433.
   PubMed Web of Science ®Google Scholar
• Monath TP, Cropp CB, Harrison AK. Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Investig J Tech Methods Pathol. 1983;48:399–410.
   PubMed Web of Science ®Google Scholar
• Samuel MA, Wang H, Siddharthan V, et al. Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A. 2007;104:17140–17145.
   PubMed Web of Science ®Google Scholar
• Sampson BA, Ambrosi C, Charlot A, et al. The pathology of human West Nile Virus infection. Hum Pathol. 2000;31:527–531.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ. Clinical manifestations and outcomes of West Nile virus infection. Viruses. 2014;6:606–623.
   PubMed Web of Science ®Google Scholar
• Anderson RC, Horn KB, Hoang MP, et al. Punctate exanthem of West Nile Virus infection: report of 3 cases. J Am Acad Dermatol. 2004;51:820–823.
   PubMed Web of Science ®Google Scholar
• Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med. 2004;141:360–365.
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Curns AT, Welburg L, et al. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol. 2008;2:477–499.
   PubMed Web of Science ®Google Scholar
• Crichlow R, Bailey J, Gardner C. Cerebrospinal fluid neutrophilic pleocytosis in hospitalized West Nile virus patients. J Am Board Fam Pract. 2004;17:470–472.
   PubMedGoogle Scholar
• Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511–515.
   PubMed Web of Science ®Google Scholar
• Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med. 2002;137:173–179.
   PubMed Web of Science ®Google Scholar
• Solomon T, Fisher AF, Beasley DWC, et al. Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clin Infect Dis. 2003;36:E140–E145.
   Google Scholar
• Kanagarajan K, Ganesh S, Alakhras M, et al. West Nile virus infection presenting as cerebellar ataxia and fever: case report. South Med J. 2003;96:600–601.
   PubMed Web of Science ®Google Scholar
• Bosanko CM, Gilroy J, Wang A-M, et al. West Nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol. 2003;60:1448–1452.
   PubMedGoogle Scholar
• Pattan SR, Dighe NS, Bhawar SB, et al. West Nile fever: an overview. J Biomed Sci Res. 2009;1:33–48.
   Google Scholar
• Kumar D, Drebot MA, Wong SJ, et al. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2004;4:1883–1888.
   PubMed Web of Science ®Google Scholar
• Jeha LE, Sila CA, Lederman RJ, et al. West Nile virus infection: a new acute paralytic illness. Neurology. 2003;61:55–59.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Libman R, Wesson K, et al. Guillain-Barré syndrome: an unusual presentation of West Nile virus infection. Neurology. 2000;55:144–146.
   PubMed Web of Science ®Google Scholar
• Park M, Hui JS, Bartt RE. Acute anterior radiculitis associated with West Nile virus infection. J Neurol Neurosurg Psychiatry. 2003;74:823–825.
   PubMed Web of Science ®Google Scholar
• Bains HS, Jampol LM, Caughron MC, et al. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol. 2003;121:205–207.
   PubMedGoogle Scholar
• Madden K. West Nile virus infection and its neurological manifestations. Clin Med Res. 2003;1:145–150.
   PubMedGoogle Scholar
• Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. 2006;66:361–365.
   PubMed Web of Science ®Google Scholar
• Barzon L, Pacenti M, Franchin E, et al. Excretion of West Nile virus in urine during acute infection. J Infect Dis. 2013;208:1086–1092.
   PubMed Web of Science ®Google Scholar
• Lanteri MC, Lee T-H, Wen L, et al. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion (Paris). 2014;54:3232–3241.
   PubMed Web of Science ®Google Scholar
• Shi P-Y, Wong SJ. Serologic diagnosis of West Nile virus infection. Expert Rev Mol Diagn. 2003;3:733–741.
   PubMed Web of Science ®Google Scholar
• Kauffman EB, Jones SA, Dupuis AP, et al. Virus detection protocols for West Nile virus in vertebrate and mosquito specimens. J Clin Microbiol. 2003;41:3661–3667.
   PubMed Web of Science ®Google Scholar
• Monini M, Falcone E, Busani L, et al. West Nile virus: characteristics of an African virus adapting to the third millennium world. Open Virol J. 2010;4:42–51.
   PubMedGoogle Scholar
• Dauphin G, Zientara S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine. 2007;25:5563–5576.
   PubMed Web of Science ®Google Scholar
• Pai A, Kleinman S, Malhotra K, et al. Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay. Transfusion (Paris). 2008;48:2184–2189.
   PubMed Web of Science ®Google Scholar
• Ziermann R, Sánchez-Guerrero SA. PROCLEIX West Nile virus assay based on transcription-mediated amplification. Expert Rev Mol Diagn. 2008;8:239–245.
   PubMed Web of Science ®Google Scholar
• Shi PY, Kauffman EB, Ren P, et al. High-throughput detection of West Nile virus RNA. J Clin Microbiol. 2001;39:1264–1271.
   PubMed Web of Science ®Google Scholar
• Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol. 2000;38:4066–4071.
   PubMed Web of Science ®Google Scholar
• Papin JF, Vahrson W, Dittmer DP. SYBR green-based real-time quantitative PCR assay for detection of West Nile Virus circumvents false-negative results due to strain variability. J Clin Microbiol. 2004;42:1511–1518.
   PubMed Web of Science ®Google Scholar
• Papin JF, Vahrson W, Larson L, et al. Genome-wide real-time PCR for West Nile virus reduces the false-negative rate and facilitates new strain discovery. J Virol Methods. 2010;169:103–111.
   PubMed Web of Science ®Google Scholar
• Parida M, Posadas G, Inoue S, et al. Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of West Nile virus. J Clin Microbiol. 2004;42:257–263.
   PubMed Web of Science ®Google Scholar
• Dyer J, Chisenhall DM, Mores CN. A multiplexed TaqMan assay for the detection of arthropod-borne flaviviruses. J Virol Methods. 2007;145:9–13.
   PubMed Web of Science ®Google Scholar
• Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis. 2003;9:376–3769.
   PubMed Web of Science ®Google Scholar
• Tilley PAG, Fox JD, Jayaraman GC, et al. Nucleic acid testing for West Nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. J Infect Dis. 2006;193:1361–1364.
   PubMed Web of Science ®Google Scholar
• Levett PN, Sonnenberg K, Sidaway F, et al. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol. 2005;43:5873–5875.
   PubMed Web of Science ®Google Scholar
• Pezzotti P, Piovesan C, Barzon L, et al. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009. Euro Surveill. 2011;16:19814.
   PubMedGoogle Scholar
• Sharifi Z, Mahmoodian Shooshtari M, Talebian A. A study of West Nile virus infection in Iranian blood donors. Arch Iran Med. 2010;13:1–4.
   PubMed Web of Science ®Google Scholar
• Malan AK, Martins TB, Hill HR, et al. Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation. J Clin Microbiol. 2004;42:727–733.
   PubMed Web of Science ®Google Scholar
• Hobson-Peters J. Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex. J Biomed Biotechnol. 2012;2012:1–15.
   PubMedGoogle Scholar
• Abraham AM, Babu M, Kavitha S, et al. A molecular method for typing Herpes simplex virus isolates as an alternative to immunofluorescence methods. Indian J Med Microbiol. 2009;27:22–26.
   PubMed Web of Science ®Google Scholar
• Hiscox A, Winter CH, Vongphrachanh P, et al. Serological investigations of flavivirus prevalence in Khammouane Province, Lao People’s Democratic Republic, 2007-2008. Am J Trop Med Hyg. 2010;83:1166–1169.
   PubMed Web of Science ®Google Scholar
• Oceguera LF, Patiris PJ, Chiles RE, et al. Flavivirus serology by Western blot analysis. Am J Trop Med Hyg. 2007;77:159–163.
   PubMed Web of Science ®Google Scholar
• Sambol AR, Hinrichs SH, Hogrefe WR, et al. Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska. Clin Vaccine Immunol. 2007;14:87–89.
   PubMed Web of Science ®Google Scholar
• Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion (Paris). 2002;42:1019–1026.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion. MMWR Morb Mortal Wkly Rep. 2002;51:833–836.
   PubMedGoogle Scholar
• Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348:2196–2203.
   PubMed Web of Science ®Google Scholar
• Alfaresi M, Elkoush A. West Nile virus in the blood donors in UAE. Indian J Med Microbiol. 2008;26:92–93.
   PubMed Web of Science ®Google Scholar
• Huang S. MAF Biosecurity New Zealand. West Nile virus seroprevalence for blood donors in the Wellington region (2007-10606) [Internet]. Wellington, NZ: MAF Biosecurity New Zealand; 2010. [cited 2016 Jan 23]. Available from: http://www.maf.govt.nz/news-resources/publications.
   Google Scholar
• Ergünay K, Saygan MB, Aydoğan S, et al. West Nile virus seroprevalence in blood donors from Central Anatolia, Turkey. Vector Borne Zoonotic Dis. 2010;10:771–775.
   PubMed Web of Science ®Google Scholar
• Schweitzer BK, Kramer WL, Sambol AR, et al. Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol. 2006;13:314–318.
   PubMed Web of Science ®Google Scholar
• Debiasi RL, Tyler KL. West Nile virus meningoencephalitis. Nat Clin Pract Neurol. 2006;2:264–275.
   PubMedGoogle Scholar
• DeSalvo D, Roy-Chaudhury P, Peddi R, et al. West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation. 2004;77:466–469.
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol. 2004;61:1210–1220.
   PubMed Web of Science ®Google Scholar
• Leyssen P, Balzarini J, De Clercq E, et al. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J Virol. 2005;79:1943–1947.
   PubMed Web of Science ®Google Scholar
• Jordan I, Briese T, Fischer N, et al. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis. 2000;182:1214–1217.
   PubMed Web of Science ®Google Scholar
• Morrey JD, Day CW, Julander JG, et al. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother. 2004;15:101–109.
   PubMedGoogle Scholar
• Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001;7:675–678.
   PubMed Web of Science ®Google Scholar
• Diamond MS. Progress on the development of therapeutics against West Nile virus. Antiviral Res. 2009;83:214–227.
   PubMed Web of Science ®Google Scholar
• Kalil AC, Devetten MP, Singh S, et al. Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;40:764–766.
   PubMed Web of Science ®Google Scholar
• Haley M, Retter AS, Fowler D, et al. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin Infect Dis. 2003;37:e88–e90.
   PubMed Web of Science ®Google Scholar
• Gould LH, Sui J, Foellmer H, et al. Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol. 2005;79:14606–14613.
   PubMed Web of Science ®Google Scholar
• Meister G, Landthaler M, Dorsett Y, et al. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA. 2004;10:544–550.
   PubMed Web of Science ®Google Scholar
• Bai F, Wang T, Pal U, et al. Use of RNA interference to prevent lethal murine West Nile virus infection. J Infect Dis. 2005;191:1148–1154.
   PubMed Web of Science ®Google Scholar
• Kumar P, Lee SK, Shankar P, et al. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med. 2006;3:e96.
   PubMed Web of Science ®Google Scholar
• Lothrop HD, Lothrop BB, Gomsi DE, et al. Intensive early season adulticide applications decrease arbovirus transmission throughout the Coachella Valley, Riverside County, California. Vector Borne Zoonotic Dis. 2008;8:475–489.
   PubMed Web of Science ®Google Scholar
• Macedo PA, Schleier JJ, Reed M, et al. Evaluation of efficacy and human health risk of aerial ultra-low volume applications of pyrethrins and piperonyl butoxide for adult mosquito management in response to West Nile virus activity in Sacramento County, California. J Am Mosq Control Assoc. 2010;26:57–66.
   PubMed Web of Science ®Google Scholar
• Ng T, Hathaway D, Jennings N, et al. Equine vaccine for West Nile virus. Dev Biol. 2003;114:221–227.
   Google Scholar
• El Garch H, Minke JM, Rehder J, et al. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. Vet Immunol Immunopathol. 2008;123:230–239.
   PubMed Web of Science ®Google Scholar
• Biedenbender R, Bevilacqua J, Gregg AM, et al. Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults. J Infect Dis. 2011;203:75–84.
   PubMed Web of Science ®Google Scholar
• Ledgerwood JE, Pierson TC, Hubka SA, et al. A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial. J Infect Dis. 2011;203:1396–1404.
   PubMed Web of Science ®Google Scholar
• Pletnev AG, Swayne DE, Speicher J, et al. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. Vaccine. 2006;24:6392–6404.
   PubMed Web of Science ®Google Scholar